Topographic maps of difference in theta power for left, right, and alternate nostril breathing compared to resting state. by Anita B. Frohlich (20660615)

Subjects:

Alpha power for left and right central-parietal ROI. by Anita B. Frohlich (20660615)

Subjects:

Topographic maps of difference in beta power. by Anita B. Frohlich (20660615)

Subjects:

Difference in theta power between breathing conditions and resting state for frontal midline ROI. by Anita B. Frohlich (20660615)

Subjects:

Topographic maps of difference in alpha functional connectivity between breathing conditions. by Anita B. Frohlich (20660615)

Subjects:

Fig 11 - by Anita B. Frohlich (20660615)

Subjects:

Topographic maps of difference in theta power between breathing conditions. by Anita B. Frohlich (20660615)

Subjects:

Difference in alpha power between breathing conditions and resting state for left and right central-parietal ROI. by Anita B. Frohlich (20660615)

Subjects:

Difference in alpha power between breathing conditions for left and right central-parietal ROI. by Anita B. Frohlich (20660615)

Subjects:

Topographic maps of difference in individual alpha/mu power between breathing conditions. by Anita B. Frohlich (20660615)

Subjects:

Topographic maps of difference in individual alpha/mu power for left, right, and alternate nostril breathing compared to resting state. by Anita B. Frohlich (20660615)

Subjects:

Experimental design and procedures. by Anita B. Frohlich (20660615)

Subjects:

Difference in theta power between breathing conditions for frontal midline ROI. by Anita B. Frohlich (20660615)

Subjects:

Participant demographics. by Anita B. Frohlich (20660615)

Subjects:

Topographic maps of difference in theta functional connectivity between breathing conditions. by Anita B. Frohlich (20660615)

Subjects:

PANAS positive. by Anita B. Frohlich (20660615)

Subjects:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Background<p>Umbilical cord blood (UCB)-derived CD4⁺CD25⁺CD127^low regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”

Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx by Juan Chen (61123)

“…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”

Reducing Dscam1 diversity decreases adult lifespan in a cluster-specific manner, also see S6 and S7 Figs. by Haiyang Dong (4783608)

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Background<p>Umbilical cord blood (UCB)-derived CD4⁺CD25⁺CD127^low regulatory T cells (Tregs) can decrease albuminuria and anti-dsDNA IgG in systemic lupus erythematosus (SLE). …”